DULIGOTUZUMAB
UNII 8PMF8YQX2T

Substance Identification & Data

This profile provides standardized clinical and technical data for Duligotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8PMF8YQX2T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1314238-96-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8PMF8YQX2T

CAS Registry Number

1314238-96-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DULIGOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C116628

National Cancer Institute reference terminology for clinical and research data.

INN ID

9646

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-138

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Duligotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DULIGOTUZUMAB

Common Names & Synonyms

BISPECIFIC HUMANIZED IGG1 MONOCLONAL ANTIBODY TO EPIDERMAL GROWTH FACTOR RECEPTOR AND HER3

DULIGOTUMAB

DULIGOTUZUMAB [INN]

DULIGOTUZUMAB [USAN]

DULIGOTUZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR/EPIDERMAL GROWTH FACTOR RECEPTOR 3) (HUMAN MONOCLONAL MEHD7945A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEHD7945A LIGHT CHAIN, DIMER